Efficacy of Sunlight Activated Synthetic Porphyrin in COVID-19 Infected Patients

NCT04371822 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

56

Enrollment

OTHER

Sponsor class

Conditions

COVID-19

Interventions

DRUG: SnPP Protoporphyrin plus Sunlight exposure
DRUG: SnPP Protoporphyrin plus Sunlight exposure
DRUG: SnPP Protoporphyrin plus Sunlight exposure
DRUG: Sulfonatoporphyrin(TPPS) plus Sunlight exposure.
OTHER: placebo

Sponsor

Kafrelsheikh University